Alcon initiated with an Equal Weight at Barclays

Barclays analyst Matt Miksic initiated coverage of Alcon (ALC) with an Equal Weight rating and $86 price target Alcon is the market leader in intraocular lenses and a share-gainer in contact lenses, the analyst tells investors in a research note. However, the firm says a slowdown in the cataract market and slower than expected equipment replacement cycle represent near-term challenges to the company’s growth.